Breaking News: WISeKey-FOSSA WISeSat-Ready Satellite Launch, Stereotaxis-Abbott Collaboration and Dell's Price Target Boost Shake Up Tech Market
- May 19th, 2023
- 615 views
WISeKey International Holding Ltd (Nasdaq: WKEY) made an exciting announcement today, revealing a new collaboration with FOSSA Systems to launch a series of WISeSat-Ready FOSSA powered satellites in partnership with SpaceX.
This joint effort aims to revolutionize the satellite industry by introducing WISeSaT Satellites, which are nanosatellites designed specifically for security-IoT applications. With this technological breakthrough, WISeSat and FOSSA are set to significantly reduce satellite costs for IoT applications while simultaneously enhancing data transmission speed. The deployment of 80 satellites projected for 2024 will ensure lower latency times, enabling near real-time data transfer.
Following this groundbreaking news, $WKEY has soared, currently trading at $3.15, which represents a remarkable increase of $0.85 (+36.96%) from the previous trading session.
In another major development, Stereotaxis, Inc. (NYSE: STXS) has announced a global collaboration with Abbott Laboratories (NYSE: ABT). This collaboration aims to integrate Abbott's EnSite X EP System with Stereotaxis' Robotic Magnetic Navigation system.
By combining Abbott's cutting-edge cardiac mapping system with Stereotaxis' advanced robotic technology, this partnership will provide healthcare professionals with highly detailed real-time diagnostic information and enable them to deliver therapy with unprecedented precision and stability.
The market has responded positively to this collaboration, driving up the stock price of Stereotaxis. Currently, $STXS is trading at $2.35, reflecting an impressive increase of $0.66 (+39.36%).
Dell Technologies Inc. (NYSE: DELL) has received a positive price target revision from Evercore ISI Group, increasing it from $50 to $55.
In the current trading session, $DELL is being traded at $47.74, representing a gain of $0.63 (+1.33%)
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login